Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Aronora, Inc. logo — Next generation therapeutics for blood clotting diseases

Aronora, Inc.

Next generation therapeutics for blood clotting diseases

Founded 2009 United States Portland, United States 10 employees Seed Biotechnology

General Information

Company Name Aronora, Inc.
Founded Year 2009
Location United States Portland, United States +1
Employees 10
Industries Biotechnology
Funding Stage Seed
Social

Get notified when Aronora, Inc. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Aronora, Inc.

Aronora, Inc. is a translational biotechnology company focused on developing next generation therapeutics for blood clotting diseases. The company, founded in 2007 and based in the United States, is committed to creating proprietary biologic therapeutics, including recombinant monoclonal antibodies and enzymes. Aronora's innovative approach aims to design therapeutic agents that can reduce the progression and growth of life-threatening blood clots without causing detrimental bleeding side effects commonly associated with existing antithrombotic drugs. Their products are targeted for use in challenging and severe cases of thrombotic blood clotting diseases. Aronora recently secured a Seed Round investment on 12 October 2023, with funding coming from NYBC Ventures. This funding will likely enable Aronora to further advance their research and development efforts in creating innovative therapeutics for blood clotting diseases, thus potentially offering promising solutions for a critical medical need. With a strong focus on biotechnology, Aronora stands poised to make a significant impact in the field of thrombotic disease treatment and contribute to the advancement of medical therapeutics. More information about the company can be found on their website at aronorabio.com.

Taxonomy: Translational research, Therapeutics, Monoclonal antibodies, Enzymes, Blood clotting diseases, Recombinant antibodies, Drug development, Antithrombotic drugs, Thrombosis, Life-threatening conditions, Innovative therapies

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round •••••• 1
Investor
12 Oct 2023

Aronora, Inc. Alternatives & Competitors

Aronora, Inc. vs
Bioventix
Bioventix

Specializing in high-affinity sheep monoclonal antibodies for biotechnology advancements

13 employees
Biotechnology, Health Care
Aronora, Inc. vs
Eldon Biologicals A/S
Eldon Biologicals A/S

Specialized blood grouping solutions designed for precision and reliability over four decades.

13 employees
Health Care, Manufacturing
Aronora, Inc. vs
International Point of Care Inc. | Fortis Life Sciences
International Point of Care Inc. | Fortis Life Sciences Canada

Providing biological reagents, diagnostic kits, clinical trials, and comprehensive laboratory testin...

29 employees
Biotechnology

FAQ About Aronora, Inc.

Next generation therapeutics for blood clotting diseases
Aronora, Inc. was founded in 2009.
Aronora, Inc. is headquartered in Portland, United States.
Aronora, Inc. operates in the following industries: Biotechnology.
Aronora, Inc. has approximately 10 employees.
Aronora, Inc. has completed 1 funding round. The latest funding stage is Seed.
Top alternatives and competitors to Aronora, Inc. include Bioventix, Eldon Biologicals A/S, International Point of Care Inc. | Fortis Life Sciences, Ablevia biotech GmbH, Zhengxi Biotechnology. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Aronora, Inc. and Bioventix are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Aronora, Inc. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy